International journal of cardiology · 2015
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Moscarella Elisabetta, Varricchio Attilio, Stabile Eugenio, Latib Azeem, Ielasi Alfonso, Tespili Maurizio, Cortese Bernardo, Calabrò Paolo, Granata Francesco, Panoulas Vasileios F, Franzone Anna, Trimarco Bruno, Bonzani Giulio, Esposito Giovanni, Colombo Antonio
Аннотация
This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.
Предметные рубрики MeSH
Absorbable ImplantsAgedAged, 80 and overAngioplasty, Balloon, CoronaryBlood Vessel Prosthesis ImplantationCohort StudiesCoronary AngiographyCoronary RestenosisDrug-Eluting StentsFemaleFollow-Up StudiesHumansItalyMaleMiddle AgedPercutaneous Coronary InterventionProspective StudiesStentsTreatment Outcome